BlackRock Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$219M Buy
2,967,665
+574,087
+24% +$46.7M 0.1% 231
2016
Q3
$209M Buy
2,393,578
+57,835
+2% +$5.47M 0.11% 228
2016
Q2
$201M Buy
2,335,743
+203,062
+10% +$17.5M 0.11% 238
2016
Q1
$170M Sell
2,132,681
-18,268
-0.8% -$1.65M 0.09% 266
2015
Q4
$271M Sell
2,150,949
-32,477
-1% -$3.92M 0.15% 155
2015
Q3
$227M Sell
2,183,426
-276,580
-11% -$35.5M 0.13% 180
2015
Q2
$304M Buy
2,460,006
+5,899
+0.2% +$743K 0.17% 142
2015
Q1
$290M Sell
2,454,107
-11,645
-0.5% -$1.4M 0.16% 147
2014
Q4
$293M Buy
2,465,752
+274,439
+13% +$30.9M 0.16% 145
2014
Q3
$246M Buy
2,191,313
+164,212
+8% +$15.6M 0.14% 159
2014
Q2
$192M Sell
2,027,101
-2,225
-0.1% -$156K 0.11% 223
2014
Q1
$144M Buy
2,029,326
+11,177
+0.6% +$885K 0.09% 251
2013
Q4
$150M Sell
2,018,149
-18,746
-0.9% -$1.31M 0.1% 238
2013
Q3
$154M Buy
2,036,895
+652,783
+47% +$51.9M 0.1% 221
2013
Q2
$111M Buy
+1,384,112
New +$102M 0.08% 267

Other funds holding VRTX